UAE-based pharmaceutical company Julphar has been given the green light by the Saudi Food and Drug Authority to resume exports to Saudi Arabia.
The company will start exporting to the Kingdom from the third quarter of this year, it said in a filing with the Abu Dhabi Securities Exchange on Thursday (Apr 30).
Saudi authorities suspended exports from Julphar in September 2018 for failing to meet regional standards.
“We are pleased to announce that more than 100 products registered in Saudi Arabia will again be available in the market,” said Sheikh Saqer Humaid Al Qasimi, chairperson of the Julphar board.
During its period of suspension, Julphar started selling into Saudi Arabia from its new production facility at King Abdullah Economic City from the end of 2019. The plant has an annual capacity for 1 billion tablets, 300 million capsules, and 30 million bottles of syrups, said the company in a statement.
Julphar is based in Ras Al Khaimah in the UAE. Its business is centered on three core business units Julphar Diabetes Solutions, General Medicines, and its consumer division Julphar Life.
© SalaamGateway.com 2020 All Rights Reserved